Archer FusionPlex® Assays: Unlocking the power of NGS for fusion detection using Anchored MultiPlex PCR (AMP™)【イルミナiSchool プロフェッショナル】

Archer FusionPlex® Assays: Unlocking the power of NGS for fusion detection using Anchored MultiPlex PCR (AMP™)【イルミナiSchool プロフェッショナル】

Darius Fugere, Product Manager, ArcherDX
Topic: Cancer Genomics : Sequencing

10月初旬より弊社でArcherDX製品の取り扱いを開始します。本ウェビナーでは、ライブラリー調製からデータ解析まで、ArcherDX社製品のテクノロジーや特長、データ解析例について、製品担当者が分かりやすく解説いたします。

 

【要旨】
In this webinar, Darius Fugere will discuss the capabilities and performance of AMP™ chemistry for the detection of known and novel gene fusions, point mutations and expression levels in FFPE and other clinical sample types. The RNA-based FusionPlex assays use AMP to enrich comprehensive sets of genes in hematological malignancies, solid tumors and sarcomas. Together with Archer Analysis, a purpose-built bioinformatics pipeline, these assays enable robust detection of gene fusions and other driver mutation types. Mr. Fugere will highlight examples of translocation, SNV, and expression profiling in blood cancer, solid tumor and sarcoma samples.



There are no related events.